MD Market Development financials
A multi-period view of the public annual-account figures reported for MD Market Development, with comparable measures and links to available source documents.
Company overviewRegistry number
0824905717
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 28, 2026
Financial evidence
Latest movements for MD Market Development
2025 versus 2024
- Operating line
- €42,975
- EBITDA
- €41,793
- Total assets
- €369,820
- Equity
- €197,580
-39.4%
-37.8%
+2.4%
+9.4%
EBITDA margin +97.2% · Equity ratio +53.4%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €42,975 | €41,793 | €369,820 | €197,580 | - |
| 202431 Dec 2024 | €70,919 | €67,242 | €361,246 | €180,627 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.